Joel’s principle area of business expertise includes: Pension and Non-Qualified Plan consulting for high income and high net worth clients in their 60’s, 70’s and 80’s. He began his career working for ...
Eli Lilly has agreed a deal to acquire French antibody-drug conjugate (ADC) specialist Mablink, continuing a series of transactions that build its position in what has become one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results